Advertisement
Screener

NURIX THERAPEUTICS, INC. (NRIX) Pre-Tax Margin

NURIX THERAPEUTICS, INC. (NRIX) Pre-Tax Margin

  • 2026-05-31: Pre-Tax Margin -993.10%.
  • 2025-11-30: Pre-Tax Margin -576.13%.
  • 2025-08-31: Pre-Tax Margin -1094.77%.
  • 2025-05-31: Pre-Tax Margin -96.93%.

Complete source-backed pre-tax margin history.

Available history
2019-11-30 to 2026-05-31
Data captured

Historical Pre-Tax Margin

DatePre-Tax Margin
2026-05-31-993.10%
2025-11-30-576.13%
2025-08-31-1094.77%
2025-05-31-96.93%
2025-02-28-305.38%
2024-11-30-440.69%
2024-08-31-388.26%
2024-05-31-367.65%
2024-02-29-249.79%
2023-11-30-276.77%
2023-08-31-200.26%
2023-05-31-79.14%
2023-02-28-321.11%
2022-11-30-688.74%
2022-08-31-423.58%
2022-05-31-397.14%
2022-02-28-442.09%
2021-11-30-509.17%
2021-08-31-282.46%
2021-05-31-370.09%
2021-02-28-483.02%
2020-11-30-297.10%
2020-08-31-453.29%
2020-05-31-311.02%
2020-02-29-432.26%

Annual Pre-Tax Margin

DatePre-Tax Margin
2025-11-30-314.00%
2024-11-30-354.36%
2023-11-30-186.98%
2022-11-30-466.93%
2021-11-30-393.49%
2020-11-30-357.90%
2019-11-30-68.97%

Similar stocks

Stock NameCountryMarket CapPE Ratio
SELLAS Life Sciences Group, Inc. (SLS)United States$2.420B-91.87
uniQure N.V. (QURE)$2.416B-4.93
Vera Therapeutics, Inc. (VERA)United States$2.402B-7.67
Harmony Biosciences Holdings, Inc. (HRMY)United States$2.399B11.67
SUPERNUS PHARMACEUTICALS, INC. (SUPN)United States$2.517B-24.63
Immunome Inc. (IMNM)United States$2.538B-9.45
Disc Medicine, Inc. (IRON)United States$2.553B-11.40
Mineralys Therapeutics, Inc. (MLYS)United States$2.353B-6.82
Viridian Therapeutics, Inc.\DE (VRDN)United States$2.342B-5.38
MBX Biosciences, Inc. (MBX)United States$2.664B-25.36